Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) Cocktail EUA Widely Expected - Credit Suisse

November 23, 2020 7:19 AM
Credit Suisse analyst Evan Seigerman reiterated an Outperform rating and $737.00 price target on Regeneron Pharma (NASDAQ: REGN) after the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments